BioBands - Relief from Chemotherapy Nausea (CINV)

BioBands are clinically proven, effective wristbands that provide relief of nausea associated with chemotherapy, anesthesia (post-operative), travel (motion sickness) and pregnancy (morning sickness).
A BioBands wristband is a safe, simple, effective and inexpensive way of relieving nausea: whether it’s from motion sickness, morning sickness, post-surgery anesthesia, or chemotherapy treatments. Biobands are safe and easy to use. They offer quick results with no side effects. Biobands are Drug Free and Chemical Free.
The wristband utilizes acupressure, a natural pressure therapy applied to a specific acupuncture point that controls nausea and vomiting. A small bead embedded in the adjustable band presses down on the P6 (Neiguan) point, located three finger widths above the wrist crease between the tendons of the flexor surface of the forearm, approximately in the area of a watchband.
Drug-free BioBands are easy to use and have no side-effects. Simply place the adjustable band correctly on either wrist. A built in bead provides customized pressure at the P6 acupressure point on the underside of the wrist. This gentle pressure interrupts the signals that trigger nausea. Several clinical studies have confirmed significant results regarding the effectiveness from P6 acupressure for nausea relief.
This simple and inexpensive product which is so easy to use can help you resume your normal lifestyle. It is a must buy purchase for anyone suffering from nausea as a side effect of chemotherapy and/or radiation treatments.
To learn more about BioBands or to buy BioBands please click here.
You can call us for more information about how BioBands can help both chemotherapy induced nausea and vomiting (CINV)as well as radiation induced nausea and vomiting (RINV)
toll free 1-866-LIVE FOR or 1-866-548-3367
Click here for other natural products to treat chemotherapy and radiation side effects.

A Different Approach to Clinical Trials for Breast Cancer – Personalized Treatments

A recent Wall Street Journal article entitled “A New Rx for Medicine” discussed an entirely new approach to clinical trials for potential breast cancer drugs. The trial, called I-Spy 2 is a joint study between Dr. Laura Esserman, Director of the Breast Care Center at the University of California, San Francisco, and Dr. Don Berry at the MD Anderson Hospital in Houston. I-Spy 2 attempts to match experimental drugs from three companies (currently testing 5 drugs from Abbot Laboratories, Amgen Inc, and Pfizer) with the patients who might have the best response to them, as determined by the molecular makeup of the patient’s tumor. It tests multiple drugs at once with the aim to get the most effective ones into later stage trials more quickly. Conventional treatment is also combined with the drugs being tested.

A few important and differentiating points about the trial are:
1. All tumors are tested for biomarkers or molecular traits.
2. The study focuses on women with aggressive breast cancers that have not spread to other organs.
3. MRI identification and evaluation of the tumor is performed periodically to check the size.
4. Chemotherapy is given before surgery (six months of treatment with chemotherapy)
5. Standard chemotherapy is used as well as the experimental agents.
6. All data and results are evaluated during the treatment as compared to conventional trials where the results may be blind until the study reaches completion.

“The goal is to pair drug and biomarker signatures and graduate them into a small phase III trial that has gotten rid of the subset of patients that don’t benefit” stated Dr. Berry.

To read the full Wall Street Journal Article please click here.
http://online.wsj.com/article/SB10001424052748703882404575520190576846812.html

For products to help with side effects of chemotherapy and radiation please click here.
http://www.LotsToLiveFor.com